Skip to main content

Moderna starts clinical trial of booster shot targeting omicron Covid variant

The first participant in the trial has already received a dose of the omicron-specific booster shot, according to Moderna.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.